| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0005 |